BRD7P5

Across TCGA pan-cancer cohorts, BRD7P5 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of BRD7P5’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where BRD7P5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types BRD7P5 is over-expressed in tumor, although a few such as LUSC show the opposite, repressed pattern.

UCEC, COAD, and THCA are the cancer types where BRD7P5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BRD7P5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	IV	+0.115	.016	6	view →
COAD	All	II,III,IV	+0.035	.009	4	view →
THCA	Male	II,III,IV	+0.026	.032	2	view →
BRCA	All	All	+0.016	.016	2	view →
LUSC	All	All	−0.017	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

BRD7P5–UCEC

Open the UCEC breakdown →